» Articles » PMID: 35948967

HIV Among People Who Inject Drugs in India: a Systematic Review

Overview
Publisher Biomed Central
Specialty Public Health
Date 2022 Aug 10
PMID 35948967
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Little is known about the epidemiology of HIV infection among HIV positive people who inject drugs (PWID) in India. Injecting drug use has emerged as an important route of HIV transmission in India. The objective of this study was to conduct a systematic review on the risk behaviours associated with HIV infection among HIV positive PWID and assess the data reported.

Methods: A systematic search of six electronic databases, Scopus, PubMed, PsycINFO, CINAHL, Embase and Ovid Medline was conducted. These databases were searched for published studies on injecting risk behaviours, sexual risk behaviours and socio-demographic factors associated with HIV infection among HIV positive PWID in India.

Results: A total of 15 studies were included in the review of which 3 studies evaluated HIV/HCV coinfection among HIV positive PWID. Older age, low educational level and employment status were significantly associated with HIV infection. Sharing of syringe and needle, frequency of injection, early initiation of injecting practice, inconsistent condom use and having multiple sexual partners were all commonly associated with HIV infection among HIV positive PWID.

Conclusion: Our study identified significant injecting and sexual risk behaviours among HIV positive PWID in India. There is an increasing HIV transmission among PWID in different states, more so in the northeastern states and in metropolitan cities in India. More studies need to be conducted in other regions of the country to understand the true burden of the disease. The lack of sufficient data among HIV positive female PWID does not preclude the possibility of a hidden epidemic among female PWID. The need of the hour is for the prevention of further transmission by this high-risk group through the provision of comprehensive programs, surveillance and robust continuation of harm reduction services.

Citing Articles

Prevalence and associated factors of HIV among female sex workers in Eastern and Southern Africa: Systematic review and meta-analysis.

Tesfie T, Yismaw G, Yirsaw B, Abuhay H, Alemayehu M, Derseh N PLoS One. 2024; 19(12):e0313868.

PMID: 39621614 PMC: 11611193. DOI: 10.1371/journal.pone.0313868.


Expanding single-venue services to better engage young people who inject drugs: insights from India.

Ganapathi L, Srikrishnan A, McFall A, Gunaratne M, Kumar M, Lucas G Harm Reduct J. 2024; 21(1):170.

PMID: 39272091 PMC: 11401385. DOI: 10.1186/s12954-024-01084-w.


Current status of harm reduction in India: Are we doing enough?.

Parmar A, Chakraborty R, Balhara Y Indian J Psychiatry. 2024; 66(4):388-391.

PMID: 38778856 PMC: 11107929. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_963_23.


HIV, hepatitis B & C in people who inject drugs in India: A systematic review of regional heterogeneity & overview of opioid substitution treatment.

Shukla L, Shivaprakash P, Suresh Kumar M Indian J Med Res. 2024; 158(5&6):522-534.

PMID: 38265946 PMC: 10878493. DOI: 10.4103/ijmr.ijmr_1930_23.


Network centrality and HIV prevention service use among people who inject drugs: Findings from a sociometric network cohort in New Delhi, India.

Prata Menezes N, Mehta S, Wesolowski A, Clipman S, Srikrishnan A, Kumar M Addiction. 2023; 119(3):570-581.

PMID: 37967827 PMC: 11003398. DOI: 10.1111/add.16379.


References
1.
Bluthenthal R, Kral A, Lorvick J, Watters J . Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol. 1998; 18(1):61-83. DOI: 10.1080/01459740.1997.9966150. View

2.
Chelleng P, Borkakoty B, Chetia M, Das H, Mahanta J . Risk of hepatitis C infection among injection drug users in Mizoram, India. Indian J Med Res. 2009; 128(5):640-6. View

3.
Scheibe A, Young K, Moses L, Basson R, Versfeld A, Spearman C . Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey. Harm Reduct J. 2019; 16(1):28. PMC: 6460775. DOI: 10.1186/s12954-019-0298-2. View

4.
Chakrapani V, Newman P, Shunmugam M, Dubrow R . Social-structural contexts of needle and syringe sharing behaviours of HIV-positive injecting drug users in Manipur, India: a mixed methods investigation. Harm Reduct J. 2011; 8:9. PMC: 3120658. DOI: 10.1186/1477-7517-8-9. View

5.
El-Bassel N, Shaw S, Dasgupta A, Strathdee S . People who inject drugs in intimate relationships: it takes two to combat HIV. Curr HIV/AIDS Rep. 2014; 11(1):45-51. PMC: 4096813. DOI: 10.1007/s11904-013-0192-6. View